Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Neely

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Therapeutic Drug Monitoring|May 7, 2010
Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?Natella Y Rakhmanina, John N van den Anker, Steven J Soldin, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 16, 2024
RPEM: Randomized Monte Carlo parametric expectation maximization algorithmRong Chen, Alan Schumitzky, Alona Kryshchenko, et al.
Journal of Clinical Pharmacology|August 4, 2022
Model-Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill PatientsSumith K Mathew, Shoma V Rao, Ratna Prabha, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2026
Predictive accuracy of population meropenem models in critically ill pneumonia patientsAdrian Valadez, Emma Harlan, Colin Jeantet, et al.
Therapeutic Drug Monitoring|July 26, 2016
A Nonparametric Pharmacokinetic Approach to Determine the Optimal Dosing Regimen for 30-Minute and 3-Hour Meropenem Infusions in Critically Ill PatientsSumith K Mathew, Binu S Mathew, Michael N Neely, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2013
Software for dosage individualization of voriconazole for immunocompromised patientsWilliam W Hope, Michael Vanguilder, J Peter Donnelly, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2017
Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin DosingMichael N Neely, Lauren Kato, Gilmer Youn, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 10, 2012
Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunctionJosé G Montoya, Michael N Neely, Sudhir Gupta, et al.
Therapeutic Drug Monitoring|November 15, 2019
Nonparametric Population Pharmacokinetic Modeling of Isoniazid in Colombian Patients With TuberculosisCarlos A Rodriguez, Andres F Zuluaga, Michael N Neely, et al.
Antimicrobial Agents and Chemotherapy|September 9, 2020
Building Optimal Three-Drug Combination Chemotherapy RegimensG L Drusano, Michael N Neely, Sarah Kim, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Therapeutic Drug Monitoring|May 7, 2010
Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?Natella Y Rakhmanina, John N van den Anker, Steven J Soldin, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 16, 2024
RPEM: Randomized Monte Carlo parametric expectation maximization algorithmRong Chen, Alan Schumitzky, Alona Kryshchenko, et al.
Journal of Clinical Pharmacology|August 4, 2022
Model-Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill PatientsSumith K Mathew, Shoma V Rao, Ratna Prabha, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2026
Predictive accuracy of population meropenem models in critically ill pneumonia patientsAdrian Valadez, Emma Harlan, Colin Jeantet, et al.
Therapeutic Drug Monitoring|July 26, 2016
A Nonparametric Pharmacokinetic Approach to Determine the Optimal Dosing Regimen for 30-Minute and 3-Hour Meropenem Infusions in Critically Ill PatientsSumith K Mathew, Binu S Mathew, Michael N Neely, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2013
Software for dosage individualization of voriconazole for immunocompromised patientsWilliam W Hope, Michael Vanguilder, J Peter Donnelly, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2017
Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin DosingMichael N Neely, Lauren Kato, Gilmer Youn, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 10, 2012
Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunctionJosé G Montoya, Michael N Neely, Sudhir Gupta, et al.
Therapeutic Drug Monitoring|November 15, 2019
Nonparametric Population Pharmacokinetic Modeling of Isoniazid in Colombian Patients With TuberculosisCarlos A Rodriguez, Andres F Zuluaga, Michael N Neely, et al.
Antimicrobial Agents and Chemotherapy|September 9, 2020
Building Optimal Three-Drug Combination Chemotherapy RegimensG L Drusano, Michael N Neely, Sarah Kim, et al.
Pageof 9